SLU-PP-332 Certificate of Analysis: Analytical Verification & Standards
A Certificate of Analysis (COA) for SLU-PP-332 provides definitive empirical proof of compound identity, purity, and safety profiles required for rigorous preclinical research. PX1 Research mandates lot-specific third-party testing using HPLC and Mass Spectrometry to guarantee chemical integrity for all laboratory applications.
Quick answer
A Certificate of Analysis (COA) for SLU-PP-332 provides definitive empirical proof of compound identity, purity, and safety profiles required for rigorous preclinical research. PX1 Research mandates lot-specific third-party testing using HPLC and Mass Spectrometry to guarantee chemical integrity for all laboratory applications.
Key takeaways
- A SLU-PP-332 [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) is an official analytical report issued by an independent, ISO 17025-accredited testing laboratory that validates the identity, purity, and safety profile of a specific production lot.
- SLU-PP-332 is a novel synthetic small-molecule estrogen-related receptor (ERR) agonist specifically designed to target ERRα, ERRβ, and ERRγ nuclear receptor isoforms.
- A valid [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) for SLU-PP-332 must provide clear quantitative data across several core analytical parameters.
- Reverse-phase high-performance liquid chromatography (RP-HPLC) serves as the primary quantitative assay for determining chemical purity in peptide and small-molecule research compounds.
Direct Answer: What Is a SLU-PP-332 Certificate of Analysis?
A SLU-PP-332 Certificate of Analysis (COA) is an official analytical report issued by an independent, ISO 17025-accredited testing laboratory that validates the identity, purity, and safety profile of a specific production lot. It utilizes reverse-phase high-performance liquid chromatography (RP-HPLC) to confirm chemical purity exceeding 98% and electrospray ionization mass spectrometry (ESI-MS) to verify precise molecular weight, ensuring batch-to-batch consistency for preclinical laboratory research.
Without a verifiable, lot-specific COA, researchers risk using degraded or contaminated reagents that compromise cellular assays, disrupt signal transduction studies, and yield unrepeatable experimental data.
SLU-PP-332 Chemical Profile and ERRα Agonism Mechanism
SLU-PP-332 is a novel synthetic small-molecule estrogen-related receptor (ERR) agonist specifically designed to target ERRα, ERRβ, and ERRγ nuclear receptor isoforms. In vitro studies demonstrate that SLU-PP-332 acts as a potent pan-ERR agonist, with heightened selectiveness toward ERRα, a nuclear receptor that plays a pivotal role in regulating mitochondrial biogenesis, oxidative phosphorylation, and cellular energy homeostasis. Researchers investigating mitochondrial kinetics and metabolic flux rely on high-purity SLU-PP-332 research compound to isolate nuclear receptor signaling pathways without confounding chemical contaminants.
Preclinical rodent models indicate that ERRα activation via synthetic agonists like SLU-PP-332 enhances oxidative gene expression in skeletal muscle and cardiac tissues. Because ERRα regulates the transcription of key enzymes involved in fatty acid oxidation, respiratory chain complex assembly, and pyruvate metabolism, accurate biochemical testing documented on a COA is critical. Inconsistent purity or structural degradation in non-certified samples can induce off-target cytotoxicity, altering experimental outcomes in high-throughput cell assays or gene expression profiling.
Essential Components of an Authentic SLU-PP-332 COA
A valid Certificate of Analysis for SLU-PP-332 must provide clear quantitative data across several core analytical parameters. Principal among these are the assay purity percentage, observed molecular weight via mass spectrometry, physical appearance (typically a white to off-white lyophilized powder), residual solvent analysis, and bacterial endotoxin levels. Every certificate must clearly display the unique batch or lot number, date of manufacture, date of analytical testing, and the specific testing protocols utilized by the independent laboratory.
When evaluating a slu-pp-332 certificate of analysis, academic and industrial researchers should confirm that the documentation is generated per specific lot rather than presented as a generic or static specification sheet. Generic documentation fails to capture batch-to-batch synthetic variance. At PX1 Research, every batch undergoes individual testing to guarantee that parameters match or exceed established reference standards before being made available for purchase across our catalog of research peptides.
Purity Verification: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC)
Reverse-phase high-performance liquid chromatography (RP-HPLC) serves as the primary quantitative assay for determining chemical purity in peptide and small-molecule research compounds. During RP-HPLC testing, the sample is dissolved in a suitable mobile phase and passed under high pressure through a stationary hydrophobic column. Compounds separate based on their partitioning coefficients between the mobile phase and stationary phase, generating distinct retention times detected via UV spectrophotometry (typically monitored at 214 nm or 254 nm).
The resulting chromatogram displays a dominant peak corresponding to the target analyte alongside minor secondary peaks representing synthetic side-products, truncated sequences, or degradation fragments. Purity is calculated using the peak area percentage (Area Under the Curve, or AUC). A verifiable COA for SLU-PP-332 must demonstrate an AUC purity of at least 98.0%, showing baseline resolution between the primary analyte peak and any trace impurities.
Identity Verification: Mass Spectrometry (MS) and Molecular Weight
While RP-HPLC establishes chemical purity and quantifies impurities, it cannot independently confirm chemical identity. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) is required to determine the precise molecular weight of the synthesized compound. Mass spectrometry ionizes the molecule and measures the mass-to-charge ratio (m/z), yielding a clear spectral fingerprint that must match the calculated theoretical monoisotopic mass of SLU-PP-332.
In a compliant slu-pp-332 certificate of analysis, the mass spectrum will exhibit a prominent single peak matching the expected ionized species. Discrepancies between calculated and observed mass indicate improper structural synthesis, incomplete deprotection, or significant structural oxidation. Verifying identity through mass spectral data ensures that laboratory experiments measure true receptor-ligand interaction dynamics rather than target activity driven by isomeric or structurally altered artifacts.
Endotoxin Quantification and Bioburden Control
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant threat to cell culture assays and in vivo preclinical rodent models. Endotoxin contamination triggers immune activation via Toll-like Receptor 4 (TLR4) signaling, inducing inflammatory cytokine release (e.g., TNF-α, IL-6) that can obscure metabolic data, cause cellular toxicity, or confound studies on nuclear receptor signaling.
PX1 Research mandates rigorous endotoxin quantification using the Limulus Amebocyte Lysate (LAL) assay or chromogenic recombinant Factor C (rFC) assays for all compounds. COAs provided by PX1 Research document endotoxin levels expressed in Endotoxin Units per milligram (EU/mg), maintaining thresholds well below standard preclinical tolerance limits (typically < 0.5 EU/mg). This strict bioburden control ensures that observed cellular responses are attributable solely to the pharmacological activity of SLU-PP-332.
Verifying Supplier Integrity: USA Manufacturing & ISO 17025 Testing
Evaluating supplier quality requires looking beyond raw numbers to verify the authenticity and independence of the analytical testing process. Reliable suppliers utilize ISO 17025-accredited third-party testing facilities that operate independently from the synthesis lab. ISO 17025 accreditation confirms that the testing laboratory complies with international standards for technical competence, instrument calibration, and analytical method validation.
PX1 Research manufactures compounds within USA-based, GMP-compliant facilities and subjects every production batch to rigorous double-blind testing. Each lot of SLU-PP-332 is accompanied by a transparent, traceable COA featuring verifiable batch identifiers, laboratory signatures, and raw chromatographic datasets. Researchers seeking high-purity reagents for ongoing assays can establish an institutional lab account to obtain bulk lot documentation and continuous supply support.
Comparative Analysis: SLU-PP-332 and Related Metabolic Research Compounds
In metabolic and mitochondrial research, SLU-PP-332 is frequently evaluated alongside other investigational agents targeting energy expenditure, NAD+ metabolism, and mitochondrial biogenesis. Comparative preclinical studies evaluate the distinct mechanisms of pan-ERR agonists against compounds such as 5-amino-1MQ, an NNMT inhibitor, MOTS-c, a mitochondrial-derived peptide, and GW501516 research models focused on PPARδ activation.
While PPARδ agonists and NNMT inhibitors alter metabolic kinetics via enzyme inhibition or transcription factor modulation, SLU-PP-332 specifically mimics physical exercise-induced gene expression profiles by activating ERR nuclear receptors. Researchers exploring multi-target metabolic signaling pathways can review detailed comparative data in our metabolic research peptides analytical hub and our broader preclinical research library.
Handling, Reconstitution, and Storage Protocols for Laboratory Use
To maintain the analytical purity verified on the COA, laboratory personnel must follow standardized handling and storage protocols. Lyophilized SLU-PP-332 powder should be stored in a desiccated environment at -20°C or -80°C away from light exposure to prevent hydrolysis or thermal degradation over extended periods.
Reconstitution should be conducted under sterile laminar flow hoods using suitable high-purity solvents. While many standard peptides dissolve readily in bacteriostatic or sterile water, small-molecule ERR agonists like SLU-PP-332 typically require organic solvents such as dimethyl sulfoxide (DMSO) or ethanol for initial solubilization, followed by dilution into aqueous buffers (e.g., PBS) for in vitro cell culture applications. Reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which can induce molecular precipitation or chemical breakdown.
PX1 Research Operational Standards and Quality Commitment
PX1 Research sets the industry standard for research-grade compound distribution across the United States. Every lot of SLU-PP-332 is synthesized domestically in state-of-the-art facilities and subjected to stringent quality control before entering inventory. By providing comprehensive analytical documentation—including full-spectrum HPLC chromatograms, mass spectra, and endotoxin reports—PX1 Research gives investigators absolute confidence in their experimental reagents.
Orders placed Monday through Friday ship same-day from our dual fulfillment hubs located in California and Arizona, minimizing transit times and reducing temperature fluctuations during shipping. For laboratory managers requiring high-throughput batch consistency, custom packaging, or verifiable COA archives, PX1 Research provides dedicated support to streamline procurement and maintain seamless research continuity.
Frequently Asked Questions
What information is included in a SLU-PP-332 Certificate of Analysis?
A comprehensive SLU-PP-332 COA includes the lot number, manufacture date, physical appearance, assay purity determined by RP-HPLC, exact mass identity confirmed by ESI-MS, endotoxin levels (EU/mg), and testing validation signatures from an ISO 17025-accredited laboratory.
How does RP-HPLC verify the purity of SLU-PP-332?
RP-HPLC separates the primary compound from synthesis byproducts using liquid chromatography under high pressure. The area under the primary peak relative to total peak area (AUC percentage) establishes the exact purity level, which must equal or exceed 98.0% for research use.
Why is Mass Spectrometry essential on a COA?
Mass Spectrometry measures the precise mass-to-charge ratio of the compound, confirming that the synthesized molecule matches the calculated molecular weight of SLU-PP-332. This proves compound identity beyond pure HPLC peak isolation.
What are acceptable endotoxin limits for SLU-PP-332 in laboratory research?
For robust in vitro and preclinical research, endotoxin levels should ideally be below 0.5 EU/mg. Low bioburden prevents TLR4 immune activation and inflammatory signaling that could interfere with metabolic cell assays.
How should lyophilized SLU-PP-332 be stored upon receipt?
Lyophilized SLU-PP-332 should be stored at -20°C or -80°C in a dry, dark environment. Proper storage prevents moisture accumulation and structural degradation, preserving the purity certified on the COA.
Can I request a lot-specific COA prior to placing an institutional order?
Yes, PX1 Research provides lot-specific Certificates of Analysis for all current inventory upon request. Institutional buyers can verify raw chromatographic data and mass spectra before procurement.
What solvent is recommended for reconstituting SLU-PP-332 in cell culture studies?
SLU-PP-332 is typically reconstituted in high-purity laboratory-grade DMSO to create a concentrated stock solution, which can then be diluted into culture media or aqueous buffers for specific in vitro assays.
How does SLU-PP-332 differ from PPARδ agonists in preclinical models?
SLU-PP-332 acts specifically as a pan-ERR agonist (targetting ERRα/β/γ) to promote mitochondrial biogenesis and exercise-mimetic transcription, whereas PPARδ agonists like GW501516 act on peroxisome proliferator-activated receptors regulating lipid oxidation pathways.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.